ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintTitle ChevronIcon Twitter
Consumer Non-Durables

Rohto Pharmaceutical Co., Ltd.

Business Summary

Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. Its products include eye drops, contact lens care, dermal medicines, skin care, internal medicines, cold remedies, test kits, and denture cleansers. Its operations are carried out through the following segments: Japan, America, Europe, Asia, and Others. The company was founded by Anmin Yamada on February 22, 1899 and is headquartered in Osaka, Japan.

Financial Highlights

Mar 2020 JPYUSD
Revenue188,375M1,732.56M
Gross Profit112,697M1,036.52M
Operating income22,882M210.45M
Income before tax21,730M199.86M
Net income15,409M141.72M
EBITDA29,819M274.25M
Diluted EPS134.711.23
Dividends Per Share260.23
Total Assets215,301M1,994.35M
Total liabilities75,266M697.19M
Total equity139,283M1,290.19M
Operating cash flow19,040M175.11M
Currency in JPYCurrency in USD

Historical Data

 Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Revenue 167,016M 154,599M 171,795M 183,672M 188,375M
Gross Profit 98,300M 90,012M 99,771M 108,322M 112,697M
Operating income 15,683M 15,452M 18,755M 20,551M 22,882M
Income before tax 14,303M 14,752M 16,820M 16,300M 21,730M
Net income 9,098M 10,011M 9,289M 9,800M 15,409M
EBITDA 22,131M 21,375M 24,669M 26,955M 29,819M
Diluted EPS 79.69 87.57 81.19 85.65 134.71
Dividends Per Share 20 21 22 25 26
Total Assets 179,573M 181,543M 198,166M 200,953M 215,301M
Total liabilities 68,302M 63,145M 69,723M 68,762M 75,266M
Total equity 110,809M 118,002M 127,685M 131,272M 139,283M
Operating cash flow 11,324M 13,428M 19,154M 21,745M 19,040M
 Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Revenue 1,390.82M 1,427.67M 1,550.04M 1,656.27M 1,732.56M
Gross Profit 818.59M 831.23M 900.19M 976.80M 1,036.52M
Operating income 130.59M 142.69M 169.21M 185.32M 210.45M
Income before tax 119.10M 136.22M 151.76M 146.98M 199.86M
Net income 75.76M 92.44M 83.81M 88.37M 141.72M
EBITDA 184.29M 197.39M 222.57M 243.06M 274.25M
Diluted EPS 0.66 0.80 0.73 0.77 1.23
Dividends Per Share 0.16 0.19 0.19 0.22 0.23
Total Assets 1,597.69M 1,629.21M 1,863.33M 1,815.53M 1,994.35M
Total liabilities 607.69M 566.67M 655.59M 621.24M 697.19M
Total equity 985.88M 1,058.97M 1,200.61M 1,185.99M 1,290.19M
Operating cash flow 94.30M 124.00M 172.81M 196.08M 175.11M

Valuation Measures

Mar 2020
PER21.90
ROA7.40%
ROE11.39%
Operating margin12.14%
Profit margin8.17%

Key executives

  • Chairman & Chief Executive Officer: Kunio Yamada
  • President, COO & Representative Director: Toshiaki Yoshino
  • Manager-Finance & Accounting: Motohide Arai
  • Director & Vice President: Masaya Saito
  • Senior Executive Officer: Yasuhiro Yamada

Shareholders

  • SPARX Asset Management Co., Ltd. (8.0%)
  • MFS International (UK) Ltd. (7.1%)
  • International Value Advisers LLC (5.0%)
  • Mitsubishi UFJ Financial Group, Inc. (4.2%)
  • Rohto Pharmaceutical Co., Ltd. (3.4%)
  • YAMADA KIYOKO (2.5%)
  • Nomura Asset Management Co., Ltd. (2.4%)
  • YAMADA FAMILY /ROHTO PHARMACEUTICAL/ (2.3%)
  • The Vanguard Group, Inc. (2.2%)
  • Sansho Kosan KK (2.2%)

Contact Details

  • Website:http://www.rohto.co.jp
  • Address: 1-8-1 Tatsumi-nishi, Ikuno-Ku, Osaka, 544-8666, Japan
  • Phone: +81.6.6758.1231

Related Companies

  • Ophthalmos SA
  • A.J. North (Pty) Ltd.
  • Mayado Pharmaceutical Co., Ltd.
  • Episteme Trading (Shanghai) Co. Ltd.
  • Mentholatum (Asia Pacific) Ltd.
  • Mentholatum (China) Pharmaceuticals Co. Ltd.
  • Rohto Asia Herb (Thailand) Co. Ltd.
  • Mentholatum de Mexico SA de CV
  • Mentholatum Taiwan Ltd.
  • Mentholatum Australasia Pty Ltd.
  • Rohto-Mentholatum (Bangladesh) Ltd.
  • Rohto-Mentholatum (Malaysia) Sdn. Bhd.
  • Rohto-Mentholatum Thailand Ltd.
  • Rohto Pharma (India) Pvt Ltd.
  • Tianjin Rohto Herbal Medicine Co., Ltd.
  • Rohto Pharmaceutical Employee Incentive Plan
  • Hokushinfoods Co., Ltd.
  • Nitten Pharmaceutical Co., Ltd.
  • Rohto Pharmaceutical Employee Stock Ownership Plan
  • Rohto-Mentholatum (Vietnam) Co., Ltd.
  • Medi Care Systems Co. Ltd.
  • Megro Chemical Industry Co. Ltd.
  • Mentholatum Co. Ltd.
  • Qualitech Pharma Co., Ltd.
  • Agera Laboratories, Inc.
  • Mentholatum Co., Inc.
  • MG Pharma

Competitors

  • Do Day Dream Public Co. Ltd.
Last Updated on 29 Sep, 2020

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends October 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more